Medicines Distribution Consent




2 OCTOBER

NEW ZEALAND GAZETTE

3723

Product:
Otrisal
Active Ingredient:
Sodium chloride 0.74%w/w
Dosage Form:
Nasal spray solution
New Zealand Sponsor:
Novartis Consumer Health Australasia Pty. Limited.
Manufacturer:
Novartis Consumer Health SA, Prangins, Nyon, Switzerland

Dated this 26th day of September 2003.

GRAEME GILLESPIE, Manager, Public Health Programmes, acting as Deputy Director-General, Public Health, for the period 24 September 2003 to 26 September 2003 (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go6408

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Atacand
Active Ingredient:
Candesartan cilexetil 16mg
Dosage Form:
Tablet
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer:
AstraZeneca AB, Södertälje, Sweden

Product:
Atacand
Active Ingredient:
Candesartan cilexetil 4mg
Dosage Form:
Tablet
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer:
AstraZeneca AB, Södertälje, Sweden

Product:
Atacand
Active Ingredient:
Candesartan cilexetil 8mg
Dosage Form:
Tablet
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer:
AstraZeneca AB, Södertälje, Sweden

Product:
Omnipaque
Active Ingredient:
Iohexol 388mg/mL equivalent to 180mg I/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Amersham Health Limited
Manufacturers:
Amersham Health AS, Oslo, Norway
Amersham Health, Carrigtohil, Co. Cork, Ireland
Nycomed Puerto Rico Inc, Barceloneta, Puerto Rico

Product:
Omnipaque
Active Ingredient:
Iohexol 518mg/mL equivalent to 240mg I/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Amersham Health Limited
Manufacturers:
Amersham Health AS, Oslo, Norway
Amersham Health, Carrigtohil, Co. Cork, Ireland
Nycomed Puerto Rico Inc, Barceloneta, Puerto Rico

Product:
Omnipaque
Active Ingredient:
Iohexol 647mg/mL equivalent to 300mg I/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Amersham Health Limited
Manufacturers:
Amersham Health AS, Oslo, Norway
Amersham Health Limited, Pudong, Shanghai, China
Amersham Health, Carrigtohil, Co. Cork, Ireland
Nycomed Puerto Rico Inc, Barceloneta, Puerto Rico

Product:
Omnipaque
Active Ingredient:
Iohexol 755mg/mL equivalent to 350mg I/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Amersham Health Limited
Manufacturers:
Amersham Health AS, Oslo, Norway
Amersham Health Limited, Pudong, Shanghai, China
Amersham Health, Carrigtohil, Co. Cork, Ireland
Nycomed Puerto Rico Inc, Barceloneta, Puerto Rico



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2003, No 139


Gazette.govt.nz PDF NZ Gazette 2003, No 139





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicine

🏥 Health & Social Welfare
26 September 2003
Medicines Act 1981, New Medicine, Distribution, Otrisal, Sodium chloride
  • Graeme Gillespie, Manager, Public Health Programmes, acting as Deputy Director-General, Public Health

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
Medicines Act 1981, Changed Medicines, Distribution, Atacand, Candesartan cilexetil, Omnipaque, Iohexol